A meta-analysis on the efficacy of oral theophylline in patients with stable COPD.

Author: MolfinoNéstor A, ZhangPeter

Paper Details 
Original Abstract of the Article :
Theophylline is a nonspecific inhibitor of phosphodiesterases that, despite exerting bronchodilator and anti-inflammatory effects, is a third-line therapy rarely used to treat chronic airflow limitation. We wished to evaluate the efficacy of oral theophylline as measured by improvements in trough (p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707158/

データ提供:米国国立医学図書館(NLM)

Evaluating the Efficacy of Oral Theophylline in Stable COPD

This research explores the field of [respiratory medicine] and [chronic obstructive pulmonary disease (COPD)], evaluating the efficacy of oral theophylline, a medication used to treat COPD. The researchers conducted a [meta-analysis] of existing studies to assess the effectiveness of oral theophylline in patients with stable COPD. The study found that [oral theophylline was associated with modest improvements in lung function], but it was not considered a first-line treatment for COPD.

Theophylline in COPD Treatment

The study's findings suggest that [oral theophylline may have a limited role in managing COPD symptoms]. The researchers recommend that [theophylline be considered as a third-line treatment option] after other therapies have been tried.

Navigating the Desert of Lung Disease

Just as a camel can traverse the vast desert, our respiratory system is constantly working to ensure that we can breathe easily. This research highlights the complexity of COPD and the ongoing search for effective treatment options.

Dr.Camel's Conclusion

This study provides valuable insights into the efficacy of oral theophylline for COPD. While theophylline may offer modest benefits, the study's findings suggest that it is not a first-line treatment option.

Date :
  1. Date Completed 2008-01-11
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

18046863

DOI: Digital Object Identifier

PMC2707158

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.